Skip to main content

Tomlinson Lab

Research Interests

The complement system is part of the immune system and consists of over 50 proteins. Complement serves many homeostatic physiologic functions, not least protection from infection. However, under certain conditions complement can be aberrantly and over activated and the system that normally provides effective protection against pathogens and infected/damaged cells is instead directed toward healthy cells and tissues. Mis-directed complement activation and the ensuing inflammatory response plays a central role in a plethora of diseases and disease conditions, from stroke, cancer, autoimmune disease, transplant rejection and even dementia.

The research of the Tomlinson’s lab is focused on how complement drives these pathological conditions and on ways to mitigate the effects of inappropriate complement activation. We use a combination of approaches including transgenic mice, a toolbox of complement inhibitors that are specifically targeted to anatomical sites and that inhibit different parts of the complement pathway, high resolution microscopy and various high dimensional analyses. Most of our studies utilize mouse models of disease and injury. Although the laboratory has been somewhat agnostic with regard to the type of disease/injury under study, our recent focus has been brain injury (stroke and traumatic brain injury) and composite tissue transplant. We are also interested in long-term outcomes after brain injury, particularly in the context of neurodegenerative disease and dementia.

We have developed a number of site-targeted complement inhibitors that we utilize as investigate tools in mouse models, but are also interested in translation of these inhibitors into the clinic. The laboratory has forged close collaborations with several clinicians, both within MUSC and externally, which has provided valuable perspectives for the translations of therapeutics we have developed. To this end, we have several licensed patents for complement inhibitors, some of which are in commercial development.

Publications (199 Citations)

Stephen Tomlinson, Ph.D.

Professor and Interim Chair for Research & Faculty Development

Focus: The complement system in inflammation, alloimmunity, cancer immunity and CNS injury.

Tomlinson Lab

Lab Members

Stephen Tomlinson, Ph.D.
Guiding the Boat
tomlinss@musc.edu
Office: CRI 213
843-792-7686
Mark Geesey, MS
Lab Manager/Research Spec.
geesey@musc.edu
Khalil Mallah, Ph.D.
Postdoctoral Fellow
mallah@musc.edu
Moumita Majumder, Ph.D.
Staff Scientist
majumdem@musc.edu

Rufus
Behavior Specialist
Lab Member Since 2022

 
Nityanada Chowdhury, Ph.D.
Staff Scientist
chowdhun@musc.edu
Devin Hatchell, MS
Graduate Student
hatcheld@musc.edu
Stephen Walterhouse, MS
Research Specialist
walterho@musc.edu
Reagan Brown
Undergraduate Student
brreagan@musc.edu

Contact the Lab

Room: CRI 204
Phone: 843-792-1456